Accuray Incorporated - Asset Resilience Ratio
Accuray Incorporated (ARAY) has an Asset Resilience Ratio of 3.32% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Accuray Incorporated (ARAY) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2021)
This chart shows how Accuray Incorporated's Asset Resilience Ratio has changed over time. See Accuray Incorporated (ARAY) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Accuray Incorporated's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Accuray Incorporated stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.94 Million | 3.32% |
| Total Liquid Assets | $15.94 Million | 3.32% |
Asset Resilience Insights
- Limited Liquidity: Accuray Incorporated maintains only 3.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Accuray Incorporated Industry Peers by Asset Resilience Ratio
Compare Accuray Incorporated's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Accuray Incorporated (2005–2021)
The table below shows the annual Asset Resilience Ratio data for Accuray Incorporated.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-06-30 | 3.32% | $15.94 Million | $480.10 Million | -- |
| 2018-06-30 | 0.00% | $0.00 | $378.73 Million | -- |
| 2017-06-30 | 5.88% | $23.91 Million | $406.46 Million | -4.19pp |
| 2016-06-30 | 10.07% | $47.24 Million | $469.03 Million | -3.61pp |
| 2015-06-30 | 13.68% | $64.31 Million | $469.97 Million | -2.38pp |
| 2014-06-30 | 16.07% | $79.55 Million | $495.19 Million | -5.17pp |
| 2013-06-30 | 21.24% | $101.08 Million | $475.93 Million | +20.91pp |
| 2012-06-30 | 0.33% | $1.56 Million | $473.17 Million | -0.37pp |
| 2011-06-30 | 0.70% | $3.17 Million | $455.78 Million | -37.26pp |
| 2010-06-30 | 37.95% | $99.88 Million | $263.18 Million | +14.40pp |
| 2009-06-30 | 23.56% | $64.63 Million | $274.39 Million | -5.44pp |
| 2008-06-30 | 28.99% | $85.54 Million | $295.00 Million | +28.99pp |
| 2006-06-30 | 0.00% | $1.00K | $138.62 Million | -0.18pp |
| 2005-06-30 | 0.18% | $158.00K | $86.86 Million | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more